Neogen (NEOG) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Neogen Corporation  (NASDAQ: NEOG)
 

Neogen Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Neogen Corporation inventory turnover ratio, the Neogen Corporation's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.7 in the third quarter 2026, NEOG's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Neogen in Feb 28 2026 quarter, has decreased to 135 days, compare to 144 days, in the Nov 30 2025 quarter.

Within Healthcare sector 148 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 36 in the second quarter 2026, to 1218.

NEOG Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neogen Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEOG Inventory Turnover Ratio (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter		 (May 31 2025)
IV. Quarter		 (Feb 28 2025)
III. Quarter
Y / Y Inventory Growth -21.29 % -17.91 % -2.61 % 0.84 % 12.64 %
Y / Y Cost of Sales Growth 1.82 % 0.85 % 1.79 % 8.67 % -0.9 %
Inventory Turnover Ratio (TTM) 2.7 2.53 2.41 2.39 2.34
NEOG's Total Ranking # 1218 # 36 # 47 # 404 # 83
Average inventory processing period 135 144 151 153 156
Seq. Inventory Growth -0.65 % -15.85 % 1.34 % -7.1 % 3.62 %
Seq. Cost of Sales Growth -5.08 % 3.51 % -14.93 % 21.82 % -5.98 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 6
Healthcare Sector # 149
Overall Market # 1218

Inventory Turnover Ratio Statistics
High Average Low
3.3 2.6 1.88
(Aug 31 2023)   (Feb 28 2013)



NEOG Company Profile >> Back to NEOG Efficiency Comparisons >> Compare NEOG Inventory Turnover Ratio to its Competitors

Financial Statements
Neogen's Inventories $ 162 Millions Visit NEOG's Balance sheet
Neogen's Cost of Revenues TTM $ 478 Millions Visit NEOG's Income Statement
What are NEOG's Sales? Visit NEOG's Sales by Segment

Other Inventory Turnover Ratios
Neogen's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NEOG's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NEOG's Competitors
Inventory Turnover Ratio for NEOG's Suppliers
Inventory Turnover Ratio for NEOG's Customers

You may also want to know
NEOG's Sales Growth Rates NEOG's Pe Price to earnings ratio NEOG's Receivables Turnover Ratio NEOG's Stock Quote
NEOG's Net Income Growth Rates NEOG's Ps Price to Sales ratio NEOG's Sales per Employee NEOG's Asset Turnover Ratio
NEOG's Net Margin NEOG's Pb Price to Book ratio NEOG's Financial Strength Ratios NEOG's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Feb 28 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Feb 28 2026 Inventories at quarter ending Feb 28 2026
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Twist Bioscience Corporation  6.76 $ 196.251  Millions$ 29  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions

Date modified: 2026-09-08T15:11:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.